Advertisement

Infectious Arthritis

  • Nicola BermanEmail author
  • Brian D. Golden
Chapter

Abstract

Infectious arthritis, due to viral, bacterial, or fungal etiologies, is a common cause of joint inflammation and can vary in clinical presentation based on the particular infectious etiology and the host characteristics. Though bacterial organisms are the most common and usually present with a monoarticular or oligoarticular arthritis, viral arthritis predominantly presents with polyarticular involvement and can mimic inflammatory arthritis such as rheumatoid arthritis. The most important aspect of evaluation is to perform an arthrocentesis in order to identify the organism, or in cases of viruses, sending the appropriate serologic workup. Following this, antibiotic treatment should be tailored to the correct organism, and additional measures such as drainage should be considered. Prompt evaluation is important to prevent long-term sequelae of infection and inflammation leading to permanent joint damage.

Keywords

Infection Arthritis MSSA/MRSA Prosthetic joint infection Arthrocentesis 

References

  1. 1.
    Cooper C, Cawley MI. Bacterial arthritis in an English health district: a 10 year review. Ann Rheum Dis. 1986;45:458–63.CrossRefGoogle Scholar
  2. 2.
    Haug JB, Harthug S, Kalager T, et al. Bloodstream infections at a Norwegian university hospital, 1974–1979 and 1988–89: changing etiology, clinical features, and outcome. Clin Infect Dis. 1994;19:246–56.CrossRefGoogle Scholar
  3. 3.
    Ross JJ, Saltzman CL, Carling P, et al. Pneumococcal septic arthritis: review of 190 cases. Clin Infect Dis. 2003;36:319–27.CrossRefGoogle Scholar
  4. 4.
    Kaandorp CJ, Dinant HJ, van de Laar MA, et al. Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis. 1997;56:470–5.CrossRefGoogle Scholar
  5. 5.
    Muñoz-Egea MC, Blanco A, Fernández-Roblas R, et al. Clinical and microbiological characteristics of patients with septic arthritis: a hospital-based study. J Orthop. 2014;11(2):87–90.CrossRefGoogle Scholar
  6. 6.
    Horowitz DL, Horowitz S, Barilla-LaBarca ML. Approach to septic arthritis. Am Fam Physician. 2011;84(6):653–60.PubMedGoogle Scholar
  7. 7.
    Ross JJ. Septic arthritis of native joints. Infect Dis Clin N Am. 2017;31(2):203–18.CrossRefGoogle Scholar
  8. 8.
    Goldenberg DL. Septic arthritis and other infections of rheumatologic significance. Rheum Dis Clin N Am. 1991;17:149.Google Scholar
  9. 9.
    Dubost JJ, Fis I, Denis P, et al. Polyarticular septic arthritis. Medicine (Baltimore). 1993;72:296.CrossRefGoogle Scholar
  10. 10.
    Ross JJ, Shamsuddin H. Sternoclavicular septic arthritis: review of 180 cases. Medicine (Baltimore). 2004;83:139.CrossRefGoogle Scholar
  11. 11.
    Li SF, Henderson J, Dickman E, et al. Laboratory tests in adults with monoarticular arthritis: can they rule out a septic joint? Acad Emerg Med. 2004;11:276–80.CrossRefGoogle Scholar
  12. 12.
    Goldenberg DL, Cohen AS. Acute infectious arthritis. Am J Med. 1976;60:369–77.CrossRefGoogle Scholar
  13. 13.
    Shen CJ, Wu MS, Lin KH, et al. The use of procalcitonin in the diagnosis of bone and joint infections: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2013;32:807–14.CrossRefGoogle Scholar
  14. 14.
    Ross JJ, Davidson L. Methicillin-resistant. Rheumatology (Oxford). 2005;44:1197–8.CrossRefGoogle Scholar
  15. 15.
    Sharff KA, Richards EP, Townes JM. Clinical management of septic arthritis. Curr Rheumatol Rep. 2013;15(6):1–9.CrossRefGoogle Scholar
  16. 16.
    Weston VC, Jones AC, Bradbury N, et al. Clinical features and outcome of septic arthritis in a single UK Health District 1982–1991. Ann Rheum Dis. 1999;58:214–9.CrossRefGoogle Scholar
  17. 17.
    Gupta MN, Sturrock RD, Field M. Prospective comparative study of patients with culture proven and high suspicion of adult onset septic arthritis. Ann Rheum Dis. 2003;62:327–31.CrossRefGoogle Scholar
  18. 18.
    Ross JJ, Saltzman CL, Carling P, Shapiro DS. Pneumococcal septic arthritis: review of 190 cases. Clin Infect Dis. 2003;36:319.CrossRefGoogle Scholar
  19. 19.
    Goldenberg DL, Cohen AS. Acute infectious arthritis. A review of patients with nongonococcal joint infections (with emphasis on therapy and prognosis). Am J Med. 1976;60:369–77.CrossRefGoogle Scholar
  20. 20.
    Howard AW, Viskontas D, Sabbagh C. Reduction in osteomyelitis and septic arthritis. J Pediatr Orthop. 1999;19:705–9.PubMedGoogle Scholar
  21. 21.
    Workowski KA, Berman SM, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006;55(RR- 11):1–94.PubMedGoogle Scholar
  22. 22.
    O’Brien JP, Goldenberg DL, Rice PA. Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms. Medicine (Baltimore). 1983;62(6):395.CrossRefGoogle Scholar
  23. 23.
    García-De La Torre I, Nava-Zavala A. Gonococcal and nongonococcal arthritis. Rheum Dis Clin N Am. 2009;35:63.CrossRefGoogle Scholar
  24. 24.
    Kumar K, Saxena MB. Multifocal osteoarticular tuberculosis. Int Orthop. 1988;12:135.CrossRefGoogle Scholar
  25. 25.
    Hodgson SP, Ormerod LP. Ten-year experience of bone and joint tuberculosis in Blackburn 1978-1987. J R Coll Surg Edinb. 1990;35:259.PubMedGoogle Scholar
  26. 26.
    Yombi JC, Seyler L, Cornu O, et al. Difficult to treat osteoarticular infections. Acta Orthop Belg. 2017;83(1):110–23.PubMedGoogle Scholar
  27. 27.
    Rogo LD, Mokhtari-Azad T, Kabir MH, et al. Human parvovirus B19: a review. Acta Virol. 2014;58(3):199–213.CrossRefGoogle Scholar
  28. 28.
    Kennedy Amaral Pereira J, Schoen RT. Management of chikungunya arthritis. Clin Rheumatol. 2017;36(10):2179–86.CrossRefGoogle Scholar
  29. 29.
    Arvikar SL, Steere AC. Diagnosis and treatment of lyme arthritis. Infect Dis Clin N Am. 2015;29(2):269–80.CrossRefGoogle Scholar
  30. 30.
    Asmar BI, Andresen J, Brown WJ. Ureaplasma urealyticum arthritis and bacteremia in agammaglobulinemia. Pediatr Infect Dis J. 1998;17(1):73–6.CrossRefGoogle Scholar
  31. 31.
    Mian AN, Farney AC, Mendley SR. Mycoplasma hominis septic arthritis in a pediatric renal transplant recipient: case report and review of the literature. Am J Transplant. 2005;5:183–8.CrossRefGoogle Scholar
  32. 32.
    Mahnel R, Marth T. Progress, problems, and perspectives in diagnosis and treatment of Whipple’s disease. Clin Exp Med. 2004;4:39–43.CrossRefGoogle Scholar
  33. 33.
    Eder L, Zisman D, Rozenbaum M, et al. Clinical features and aetiology of septic arthritis in northern Israel. Rheumatology (Oxford). 2005;44:1559–63.CrossRefGoogle Scholar
  34. 34.
    Gotuzzo E, Alarcon GS, Bocanegra TS, et al. Articular involvement in human brucellosis: a retrospective analysis of 304 cases. Semin Arthritis Rheum. 1982;12:245–55.CrossRefGoogle Scholar
  35. 35.
    Phillips JE, Crane TP, Noy M, Elliott TS, Grimer RJ. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br. 2006;88:943–8.CrossRefGoogle Scholar
  36. 36.
    Berbari EF, Hanssen AD, Duffy MC, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998;27:1247–54.CrossRefGoogle Scholar
  37. 37.
    Ghanem E, Parvizi J, Burnett RS, et al. Cell count and differential of aspirated fluid in the diagnosis of infection at the site of total knee arthroplasty. J Bone Joint Surg Am. 2008;90:1637–43.CrossRefGoogle Scholar
  38. 38.
    Pääkkönen M, Peltola H. Treatment of acute septic arthritis. Pediatr Infect Dis J. 2013;32:684–68.CrossRefGoogle Scholar
  39. 39.
    Pioro MH, Mandell BF. Septic arthritis. Rheum Dis Clin N Am. 1997;23:239–25.CrossRefGoogle Scholar
  40. 40.
    Li R, Hatcher JD. Gonococcal arthritis. Bookshelf NCBI.Google Scholar
  41. 41.
    Speyer I, Breedveld FC, Dijkmans BA. Human parvovirus B19 infection is not followed by inflammatory joint disease during long term follow up. A retrospective study of 54 patients. Clin Exp Rheum. 1889;16(5):576–8.Google Scholar
  42. 42.
    Dattwyler RJ, Wormser GP, Rush TJ, et al. A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien Klin Wochenschr. 2005;117(11–12):393–7.CrossRefGoogle Scholar
  43. 43.
    Chakraborty PP, Ray S, Selvan C, et al. Poncet’s disease: AN unusual presentation of tuberculosis in a diabetic lady. World J Clin Cases. 2015;3(4):385–8.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Northwell Health Department of RheumatologyLenox Hill HospitalNew YorkUSA
  2. 2.Hofstra School of MedicineHempsteadUSA
  3. 3.NYU School of MedicineNew YorkUSA
  4. 4.NYU School of Medicine, Division of RheumatologyNYU Langone HealthNew YorkUSA

Personalised recommendations